Time’s almost up to register for Eyes On Retina 2026!
From AMD and diabetic eye disease to arterial occlusions, choroidal tumors, and pediatric retina, Eyes On Retina 2026 covers the full spectrum of retina care in one day. Attend 8 clinical sessions from leading experts live on Saturday, October 17, all built around the latest treatment and imaging protocols. Plus, earn up to 5 CE/CME credits online at no cost to you!
New Content
The Logistics of Effective Collaborative Care for Glaucoma Management
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Fleming Island, FL
Chesterfield Township, MI
Why the Best Retina Surgeons Keep Adapting Their Technique
Join Drs. Kitchens and Sridhar as they discuss how cross-institutional training broadens surgeons' perspectives and improves patient care.
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Join Drs. Vakharia and Brugger as they discuss how to utilize long-term GATHER2 and GALE data to guide patient selection and GA treatment decisions.
Topics
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Putting Scale to Work for Independent Optometry
Start the Conversation: A Free Myopia Toolkit for ECPs
Emerging Therapies and Clinical Trials in Early Diabetic Retinopathy
Spot the subtle signs of mild NPDR sooner, stage it with confidence, and know when watching and waiting stops serving your diabetic patients.
Glaukos reports positive topline phase 4 data on iDose TR in combo with cataract surgery
Latest 3-month data demonstrate clinically meaningful IOP reductions compared to cataract surgery alone.
FDA clears Surrozen's IND for DME therapy
First patient dosing in the DUET trial planned for later this year; study will be the first to evaluate humans treated with the bifunctional antibody.
Empire Forum co-chairs preview retina's new investor-industry meeting
Rishi Singh, MD, and David Eichenbaum, MD, explain what sets the inaugural Nov. 5 event apart, from an investor panel to first-time IRD podium data.
Assessing and Managing Retinal Tears as an Optometrist
Sit down with Drs. Daniel Epshtein and Jessica Haynes to review how to identify and stage retinal tears as well as decide when to refer high-risk cases.
The Logistics of Effective Collaborative Care for Glaucoma Management
Join Drs. Preeya K. Gupta, Matt Walker, and Deborah Ristvedt, as they discuss the implementation of collaborative care models for glaucoma management, highlighting the importance of trust and communication between ophthalmologists and referral optometrists.
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Explore how optometrists can address the impact of screen exposure on myopia progression and educate parents and patients on healthy digital device use.
Clinical Specialties
Why the Best Retina Surgeons Keep Adapting Their Technique
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
